152 related articles for article (PubMed ID: 20213669)
1. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site.
Torrent M; Nogués MV; Boix E
J Mol Recognit; 2011; 24(1):90-100. PubMed ID: 20213669
[TBL] [Abstract][Full Text] [Related]
2. The sulfate-binding site structure of the human eosinophil cationic protein as revealed by a new crystal form.
Boix E; Pulido D; Moussaoui M; Nogués MV; Russi S
J Struct Biol; 2012 Jul; 179(1):1-9. PubMed ID: 22579681
[TBL] [Abstract][Full Text] [Related]
3. Mapping the eosinophil cationic protein antimicrobial activity by chemical and enzymatic cleavage.
Sánchez D; Moussaoui M; Carreras E; Torrent M; Nogués V; Boix E
Biochimie; 2011 Feb; 93(2):331-8. PubMed ID: 20951760
[TBL] [Abstract][Full Text] [Related]
4. Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans.
Torrent M; Navarro S; Moussaoui M; Nogués MV; Boix E
Biochemistry; 2008 Mar; 47(11):3544-55. PubMed ID: 18293932
[TBL] [Abstract][Full Text] [Related]
5. Insights into the glycosaminoglycan-mediated cytotoxic mechanism of eosinophil cationic protein revealed by NMR.
García-Mayoral MF; Canales A; Díaz D; López-Prados J; Moussaoui M; de Paz JL; Angulo J; Nieto PM; Jiménez-Barbero J; Boix E; Bruix M
ACS Chem Biol; 2013 Jan; 8(1):144-51. PubMed ID: 23025322
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
[TBL] [Abstract][Full Text] [Related]
7. Three-dimensional crystal structure of human eosinophil cationic protein (RNase 3) at 1.75 A resolution.
Mallorquí-Fernández G; Pous J; Peracaula R; Aymamí J; Maeda T; Tada H; Yamada H; Seno M; de Llorens R; Gomis-Rüth FX; Coll M
J Mol Biol; 2000 Jul; 300(5):1297-307. PubMed ID: 10903870
[TBL] [Abstract][Full Text] [Related]
8. Role of unique basic residues in cytotoxic, antibacterial and antiparasitic activities of human eosinophil cationic protein.
Singh A; Batra JK
Biol Chem; 2011 Apr; 392(4):337-46. PubMed ID: 21303303
[TBL] [Abstract][Full Text] [Related]
9. Characterization of molecular interactions between eosinophil cationic protein and heparin.
Fan TC; Fang SL; Hwang CS; Hsu CY; Lu XA; Hung SC; Lin SC; Chang MD
J Biol Chem; 2008 Sep; 283(37):25468-25474. PubMed ID: 18593710
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil cationic protein aggregation: identification of an N-terminus amyloid prone region.
Torrent M; Odorizzi F; Nogués MV; Boix E
Biomacromolecules; 2010 Aug; 11(8):1983-90. PubMed ID: 20690710
[TBL] [Abstract][Full Text] [Related]
11. Towards the rational design of antimicrobial proteins: single point mutations can switch on bactericidal and agglutinating activities on the RNase A superfamily lineage.
Pulido D; Moussaoui M; Nogués MV; Torrent M; Boix E
FEBS J; 2013 Nov; 280(22):5841-52. PubMed ID: 23992292
[TBL] [Abstract][Full Text] [Related]
12. Comparison of human RNase 3 and RNase 7 bactericidal action at the Gram-negative and Gram-positive bacterial cell wall.
Torrent M; Badia M; Moussaoui M; Sanchez D; Nogués MV; Boix E
FEBS J; 2010 Apr; 277(7):1713-25. PubMed ID: 20180804
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of the eosinophil cationic protein antimicrobial activity.
Boix E; Salazar VA; Torrent M; Pulido D; Nogués MV; Moussaoui M
Biol Chem; 2012 Aug; 393(8):801-15. PubMed ID: 22944682
[TBL] [Abstract][Full Text] [Related]
14. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein.
Slifman NR; Loegering DA; McKean DJ; Gleich GJ
J Immunol; 1986 Nov; 137(9):2913-7. PubMed ID: 3760576
[TBL] [Abstract][Full Text] [Related]
15. Functional characterization of ECP-heparin interaction: a novel molecular model.
Hung TJ; Tomiya N; Chang TH; Cheng WC; Kuo PH; Ng SK; Lien PC; Lee YC; Chang MD
PLoS One; 2013; 8(12):e82585. PubMed ID: 24349317
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the membrane interaction mechanism of two antimicrobial RNases: RNase 3/ECP and RNase 7.
Torrent M; Sánchez D; Buzón V; Nogués MV; Cladera J; Boix E
Biochim Biophys Acta; 2009 May; 1788(5):1116-25. PubMed ID: 19366593
[TBL] [Abstract][Full Text] [Related]
17. Eosinophil cationic protein damages protoscoleces in vitro and is present in the hydatid cyst.
Ramos AL; Discipio RG; Ferreira AM
Parasite Immunol; 2006 Aug; 28(8):347-55. PubMed ID: 16879306
[TBL] [Abstract][Full Text] [Related]
18. Eosinophil cationic protein: overview of biological and genetic features.
de Oliveira PC; de Lima PO; Oliveira DT; Pereira MC
DNA Cell Biol; 2012 Sep; 31(9):1442-6. PubMed ID: 22845733
[TBL] [Abstract][Full Text] [Related]
19. The coding ECP 434(G>C) gene polymorphism determines the cytotoxicity of ECP but has minor effects on fibroblast-mediated gel contraction and no effect on RNase activity.
Rubin J; Zagai U; Blom K; Trulson A; Engström A; Venge P
J Immunol; 2009 Jul; 183(1):445-51. PubMed ID: 19542456
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of the native and the ligand-bound structures of eosinophil cationic protein: network of hydrogen bonds at the catalytic site.
Sanjeev BS; Vishveshwara S
J Biomol Struct Dyn; 2005 Jun; 22(6):657-72. PubMed ID: 15842171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
